Pantec Biosolutions AG   Report issue

For profit Phase 1
Founded: Ruggell Liechtenstein (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2016
NCT02999776
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now